Emma Andrus, Assistant Editor

Catch up on visual highlights and views from the first day of the SDPA Annual Summer Dermatology Conference in Boston, MA.

Mark Lebwohl, MD, discusses his SDPA Annual Summer Dermatology Conference session, "Inflammatory Dermatoses: A Case-Based Review."

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed improvements to hyperpigmentation in a cohort of Black patients with moderate-to-severe acne.

Omar Noor, MD, FAAD, discusses cultural competency in caring for patients with skin of color in dermatology.

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed statistically significant improvements among patients with psoriasis receiving brodalumab treatment.

Omar Noor, MD, FAAD, discusses his SDPA session, "Clinical Pearls for Pediatric and Adult Dermatology."

When sessions, late-breaking research, and more conclude, there is no shortage of things to do in historic Boston.

Click here to answer today's poll.

The conference aimed at providing dermatology physician assistants with the latest in the field begins tomorrow in Boston, Massachusetts.

A split-face study found that combination therapy proved more efficacious than microneedling alone.

Matthew Mansh, MD, FAAD, discusses inequities faced by transgender and gender-diverse patient populations.

Click here to answer this week's poll.

Researchers tested bovine sialogylcoproteins on human dermal fibroblasts.

In a murine model, application of PALA in topical fashion led to reductions in tumor grades and numbers.

Researchers also identified 50% improvement in appearance with larger spot laser use.

The new technique analyzes RNA from infant sebum samples.

Jennifer Orozco, DMSc, PA-C, DFAAPA, oversees the American Academy of Physician Associates and advocates for the role of PAs.

Despite this, researchers found that Hsp70 plasma levels did not correlate with the extent of disease.

Level Ex, Inc.'s Top Derm is changing the way dermatologists learn about skin conditions—all through a cell phone screen.

In this episode, Jonathan Silverberg, MD, PhD, MPH, discusses of the effects of environmental pollutants on atopic dermatitis, including flares, severity, and recommendations for avoiding these pollutants when possible.

Among the many sessions to be held at the 2023 Fall Clinical Dermatology Conference for PAs & NPs in Orlando, Florida, several Dermatology Times® Editorial Advisory Board members are preparing to share their knowledge and insights.

Investigators compared data among patients with vitiligo and the general population.

This Hidradenitis Suppurativa Awareness Week, the Dermatology Times® team is spotlighting the often misunderstood condition and providing clinicians with the latest information in treatment and research.

This week is Hidradenitis Suppurativa Awareness Week.

Level Ex, Inc.'s Top Derm is changing the way dermatologists learn about skin conditions—all through a cell phone screen.

The chemical peel demonstrated tolerability and photoaging improvement.

This week is Hidradenitis Suppurativa Awareness Week.

More research is needed to specify long-term efficacy of the treatment and its ideal dose.

This week is Hidradenitis Suppurativa Awareness Week.

The IL-23p19 inhibitor demonstrated long-term efficacy and safety.